| Aug 6 |
Karyopharm Therapeutics: Q2 Earnings Snapshot
|
| Aug 6 |
Karyopharm Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue of $42.8M beats by $6.59M
|
| Aug 6 |
Karyopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
| Aug 5 |
Karyopharm Therapeutics Q2 2024 Earnings Preview
|
| Jul 31 |
Karyopharm to Report Second Quarter 2024 Financial Results on August 6, 2024
|
| Jul 31 |
Earnings Preview: Assertio (ASRT) Q2 Earnings Expected to Decline
|
| Jul 25 |
Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right Now?
|
| Jul 15 |
Karyopharm Therapeutics Inc. (KPTI): Is This Penny Stock A Good Buy Right Now?
|
| Jun 1 |
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
|
| May 29 |
Karyopharm to Participate at the Jefferies Global Healthcare Conference
|
